BPTH
Price:
$0.9839
Market Cap:
$2.51M
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for ...[Read more]
Industry
Biotechnology
IPO Date
2008-03-04
Stock Exchange
NASDAQ
Ticker
BPTH
According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -2842.40%. This represents a change of 1.14% compared to the average of -228.96% of the last 4 quarters.
The mean historical ROE of Bio-Path Holdings, Inc. over the last ten years is -485.64%. The current -2842.40% ROE has changed 485.29% with respect to the historical average. Over the past ten years (40 quarters), BPTH's ROE was at its highest in in the March 2024 quarter at 120.27%. The ROE was at its lowest in in the December 2023 quarter at -764.63%.
Average
-485.64%
Median
-76.98%
Minimum
-3645.80%
Maximum
-30.30%
Discovering the peaks and valleys of Bio-Path Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.64%
Maximum Annual ROE = -30.30%
Minimum Annual Increase = -94.28%
Minimum Annual ROE = -3645.80%
Year | ROE | Change |
---|---|---|
2023 | -3645.80% | 3.64% |
2022 | -97.61% | 138.08% |
2021 | -41.00% | -43.09% |
2020 | -72.04% | 78.60% |
2019 | -40.33% | -94.28% |
2018 | -704.68% | 709.43% |
2017 | -87.06% | 6.28% |
2016 | -81.92% | 47.12% |
2015 | -55.68% | 83.75% |
2014 | -30.30% | -55.61% |
The current ROE of Bio-Path Holdings, Inc. (BPTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1261.47%
5-year avg
-779.36%
10-year avg
-485.64%
Bio-Path Holdings, Inc.’s ROE is less than Catalyst Biosciences, Inc. (1.20%), greater than Diffusion Pharmaceuticals Inc. (-55460.19%), greater than Capricor Therapeutics, Inc. (-220.26%), greater than NextCure, Inc. (-57.63%), greater than Pulmatrix, Inc. (-61.78%), greater than Bellerophon Therapeutics, Inc. (-63.72%), greater than Crinetics Pharmaceuticals, Inc. (-62.63%), greater than Applied Molecular Transport Inc. (-218.56%), greater than Aileron Therapeutics, Inc. (-47.94%), greater than Benitec Biopharma Inc. (-175.36%), greater than Onconova Therapeutics, Inc. (-144.95%), greater than Moleculin Biotech, Inc. (-100.16%), greater than Achieve Life Sciences, Inc. (-116.78%), greater than Icosavax, Inc. (-41.24%), less than Akari Therapeutics, Plc (1.04%),
Company | ROE | Market cap |
---|---|---|
1.20% | $19.42M | |
-55460.19% | $8.98M | |
-220.26% | $132.76M | |
-57.63% | $39.73M | |
-61.78% | $7.30M | |
-63.72% | $428.14K | |
-62.63% | $4.03B | |
-218.56% | $11.01M | |
-47.94% | $60.66M | |
-175.36% | $90.98M | |
-144.95% | $20.90M | |
-100.16% | $6.83M | |
-116.78% | $143.03M | |
-41.24% | $769.04M | |
1.04% | $35.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bio-Path Holdings, Inc.'s ROE?
How is the ROE calculated for Bio-Path Holdings, Inc. (BPTH)?
What is the highest ROE for Bio-Path Holdings, Inc. (BPTH)?
What is the 3-year average ROE for Bio-Path Holdings, Inc. (BPTH)?
What is the 5-year average ROE for Bio-Path Holdings, Inc. (BPTH)?
How does the current ROE for Bio-Path Holdings, Inc. (BPTH) compare to its historical average?